特一药业：关于第六届董事会第二次会议决议的公告

Group 1 - The company announced the approval of two proposals by its sixth board of directors' second meeting, which include the temporary use of idle raised funds for supplementing working capital and cash management [2] - The proposals involve utilizing part of the funds raised through a simplified procedure for specific targets in the year 2023 [2] - The announcements indicate the company's strategic approach to managing its financial resources effectively [2]